Life Sciences

Life sciences firm AbbVie, which has operations in Worcester, saw a nearly 9-percent increase in fourth-quarter revenue, helped by double-digit growth in its popular arthritis drug, Humira.

Milford-based Waters Corp., a manufacturer of laboratory instruments, on Wednesday announced the opening of its Joint Open Laboratory in Beijing. Outfitted with Waters' chromatography and mass spectrometry technologies, the analytic laboratory will be jointly operated by Waters and the Chinese Pharmacopeia Commission (ChP), according to a company statement. It is expected to serve as one of China's national technical support centers in the field of Chinese pharmaceutical standards, Waters said.

Pharmaceutical giant AbbVie, which has operations in Worcester, has boosted its earnings estimates for 2015 by 30 percent amid rising sales for its arthritis drug Humira and the launch of its treatment for hepatitis C, the company announced late last week.

Ashland-based NuVascular Technologies Inc. said it has obtained exclusive licensing rights to commercialize a stem cell device that allows the heart to repair itself and improve its functions in as little as two to four weeks.

More than $18 million was seized from accounts connected to the owners of New England Compounding Center (NECC), the Framingham pharmacy linked to the 2012 fungal meningitis outbreak, the U.S. Department of Justice said Tuesday.

AstraZeneca announced last month that it will close its manufacturing plant in Westborough by the end of...

Marlborough-based biotechnology firm RXi Pharmaceuticals said three-month observations have confirmed the effectiveness of its first product candidate, RXI-109, in the treatment of post-surgical scars.

Generex Biotechnology Corp. of Worcester, a developer of drug delivery technology, said it has entered into an agreement with Canadian medical marijuana development firm CannScience Innovations Inc. to license its drug delivery system for delivery of medical marijuana products.

Boston Scientific of Marlborough suffered a rough month in the legal system in November after two federal court juries awarded more than $45 million to eight women who claimed injuries from the medical device manufacturer's transvaginal mesh devices. What do they mean for the company?

Amid the controversy over national health care reform, the Affordable Care Act has raised serious hackles with the medical device tax, especially in Massachusetts. Now, with Republicans set to control both chambers of Congress in January, it looks like a repeal of the tax may be in the works.